A healthcare industry on the hunt for customers
It is in the economic interest of the players at the meso level to generate sales, while these must be controlled in the interests of the insured and premium payers. They operate in this contradiction, sometimes entrusted with both tasks at the same time. It could be resolved by those players at the meso level who are too often forgotten: the medical societies and associations.
Homes and hospitals
Our hospitals and care homes have improved their efficiency and continue to do so. However, human work can only be rationalized to a certain extent. The pressure to generate revenue and increase efficiency means that professionals have less and less time for patients. This has an impact on the quality of work and can lead to incorrect entries and expensive follow-up treatment.
Pharmaceutical and insurance industry
Care homes and hospitals are largely owned by the cantons. The pharmaceutical and insurance industries operate in private organizations. The role of the former is under close scrutiny, while the latter is granted freedom by the authorities and given control functions that can be problematic: Curtailing benefits helps the insurance industry to expand its sales of supplementary insurance.
Professional societies and associations
The medical associations have acquired a solid knowledge of which treatments are effective, appropriate and economical and when. They formulate this knowledge in guidelines, but do not monitor compliance at the micro level. The Fairfond Foundation is committed to inter-institutional expert audits in order to popularize and establish this urgently needed corrective.